Financhill
Back

Amgen Quote, Financials, Valuation and Earnings

Amgen Price Quote

$263.38

Amgen Key Stats

Sell
42
Amgen (AMGN) is a Sell

Day range:
$262.21 - $269.61
52-week range:
$253.30 - $346.85
Dividend yield:
3.42%
P/E ratio:
21.09
P/S ratio:
4.37
P/B ratio:
18.81%

Volume:
13.4M
Avg. volume:
4.7M
1-year change:
-4.29%
Market cap:
$141.6B
Revenue:
$28.2B
EPS:
$7.81

How Much Does Amgen Make?

Data Unavailable

Is Amgen Growing As A Company?

Data Unavailable

Amgen Stock Price Performance

  • Did Amgen Stock Go Up Last Month?
    Amgen share price went down by -8.51% last month
  • Did AMGN's Share Price Rise Over The Last Year?
    AMGN share price fell by -4.29% over the past 1 year

What Is Amgen 52-Week High & Low?

  • What Is Amgen’s 52-Week High Share Price?
    Amgen has traded as high as $346.85 over the past 52 weeks
  • What Is Amgen’s 52-Week Low Share Price?
    Amgen has traded as low as $253.30 over the past 52 weeks

Amgen Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Amgen?

Data Unavailable

Is Amgen Cash Flow Positive?

Data Unavailable

Amgen Return On Invested Capital

Data Unavailable

Amgen Earnings Date & Stock Price

  • What Is Amgen's Stock Price Today?
    A single share of AMGN can be purchased today for 263.38
  • What Is Amgen’s Stock Symbol?
    Amgen trades on the S&P500 under the ticker symbol: AMGN
  • When Is Amgen’s Next Earnings Date?
    The next quarterly earnings date for Amgen is scheduled on February 6, 2025
  • When Is AMGN's next ex-dividend date?
    Amgen's next ex-dividend date is February 14, 2025
  • How To Buy Amgen Stock?
    You can buy Amgen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Amgen Competitors

  • Who Are Amgen's Competitors?
    Below is a list of companies who compete with Amgen or are related in some way:
    • Eli Lilly and Co (LLY)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Viking Therapeutics Inc (VKTX)

Amgen Dividend Yield

Data Unavailable

Amgen Analyst Estimates

YoY Growth Past Surprise
EPS: 62.11% 9.29%
Revenue: 23.18% 0.05%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 15
Sell Recommendations: 2
Price Target: 322.43
Upside from Last Price: 22.42%

Major Shareholders

Data Unavailable